These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21658465)

  • 1. Estimating prognosis for survival after treatment of choroidal melanoma.
    Damato B; Eleuteri A; Taktak AF; Coupland SE
    Prog Retin Eye Res; 2011 Sep; 30(5):285-95. PubMed ID: 21658465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial neural networks estimating survival probability after treatment of choroidal melanoma.
    Damato B; Eleuteri A; Fisher AC; Coupland SE; Taktak AF
    Ophthalmology; 2008 Sep; 115(9):1598-607. PubMed ID: 18342942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival.
    Damato BE; Heimann H; Kalirai H; Coupland SE
    JAMA Ophthalmol; 2014 May; 132(5):605-13. PubMed ID: 24626610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monosomy 3 predicts death but not time until death in choroidal melanoma.
    Sandinha MT; Farquharson MA; McKay IC; Roberts F
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3497-501. PubMed ID: 16186325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the management of posterior uveal melanoma.
    Zhao DY; Shields CL; Shields JA; Gunduz K
    J Ophthalmic Nurs Technol; 1998; 17(2):66-71. PubMed ID: 9677975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parsimonious Models for Predicting Mortality from Choroidal Melanoma.
    Damato B; Eleuteri A; Hussain R; Kalirai H; Thornton S; Taktak A; Heimann H; Coupland SE
    Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):35. PubMed ID: 32334433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
    Isager P; Ehlers N; Overgaard J
    Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma.
    Trent JM; Meyskens FL; Salmon SE; Ryschon K; Leong SP; Davis JR; McGee DL
    N Engl J Med; 1990 May; 322(21):1508-11. PubMed ID: 2336077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of and therapy for choroidal melanoma].
    Lipski AC; Lakotka N; Riechardt AI; Willerding GD; Heufelder J; Türkmen S; Keilholz U; Moser L; Joussen AM
    Klin Monbl Augenheilkd; 2013 Oct; 230(10):1005-19. PubMed ID: 24046188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment considerations for primary uveal melanoma with choroidal metastasis to the fellow eye.
    Bourla DH; Young TA
    Semin Ophthalmol; 2007; 22(3):175-7. PubMed ID: 17763240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma.
    Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2471-80. PubMed ID: 10509639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor, node, metastasis classification of malignant ciliary body and choroidal melanoma evaluation of the 6th edition and future directions.
    Kujala E; Kivelä T
    Ophthalmology; 2005 Jun; 112(6):1135-44. PubMed ID: 15885792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prognostic model and staging for metastatic uveal melanoma.
    Eskelin S; Pyrhönen S; Hahka-Kemppinen M; Tuomaala S; Kivelä T
    Cancer; 2003 Jan; 97(2):465-75. PubMed ID: 12518371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of positive dual-modality positron emission tomography/computed tomography imaging of primary choroidal melanoma with chromosome 3 loss and tumor size.
    McCannel TA; Reddy S; Burgess BL; Auerbach M
    Retina; 2010 Jan; 30(1):146-51. PubMed ID: 20010323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma.
    Furdova A; Slezak P; Chorvath M; Waczulikova I; Sramka M; Kralik G
    Neoplasma; 2010; 57(4):377-81. PubMed ID: 20429631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Biopsy of Choroidal Melanoma after Proton Beam Radiation Therapy.
    Hussain RN; Kalirai H; Groenewald C; Kacperek A; Errington RD; Coupland SE; Heimann H; Damato B
    Ophthalmology; 2016 Oct; 123(10):2264-5. PubMed ID: 27324683
    [No Abstract]   [Full Text] [Related]  

  • 20. Chromosome 3 intratumor heterogeneity in uveal melanoma.
    Mensink HW; Vaarwater J; Kiliç E; Naus NC; Mooy N; Luyten G; Brüggenwirth HT; Paridaens D; de Klein A
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):500-4. PubMed ID: 18824727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.